919

4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide


Toggle HydrogenToggle Labels

Chemical Component Summary

Name4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
SynonymsDCC-2036
Identifiers4-[4-[(5-tert-butyl-2-quinolin-6-yl-pyrazol-3-yl)carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide
FormulaC30 H28 F N7 O3
Molecular Weight553.587
TypeNON-POLYMER
Isomeric SMILESCC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC
InChIInChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)
InChIKeyWVXNSAVVKYZVOE-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count69
Chiral Atom Count0
Bond Count73
Aromatic Bond Count29

Drug Info: DrugBank

DrugBank IDDB13005 
NameRebastinib
Groups investigational
DescriptionRebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
Synonyms
  • Rebastinib
  • Rebastinib tosylate
Categories
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Heterocyclic Compounds, Fused-Ring
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive, drug therapy
  • Protein Kinase Inhibitors
CAS number1020172-07-9

Related Resource References

Resource NameReference
Pharos CHEMBL1738757
PubChem 25066467
ChEMBL CHEMBL1738757
ChEBI CHEBI:62166